• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1型强直性肌营养不良症与肺栓塞:达比加群酯治疗成功溶解血栓

Myotonic dystrophy type 1 and pulmonary embolism: successful thrombus resolution with dabigatran etexilate therapy.

作者信息

Gallinoro Emanuele, Papa Andrea Antonio, Rago Anna, Sperlongano Simona, Cassese Antonio, Cioppa Nadia Della, Magliocca Maria Cristina Giada, Cimmino Giovanni, Golino Paolo

机构信息

Department of Cardiology, University of Campania "L. Vanvitelli", Monaldi Hospital, Naples, Italy.

Department of Anesthesiology, Monaldi Hospital, Naples, Italy.

出版信息

Acta Myol. 2018 Sep 1;37(3):227-231. eCollection 2018 Sep.

PMID:30838353
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6390112/
Abstract

Myotonic dystrophy type 1 (DM1) is the most common form of adult muscular dystrophy. It is an autosomal dominant inherited disease with multisystemic involvement. Respiratory function is often affected and respiratory failure is the most common cause of death. Pulmonary embolism is a rare cause of respiratory failure in DM1 patients, so that the best anticoagulation strategy in these patients is still unclear. We describe the case of pulmonary embolism in a DM1 patient, in which pulmonary thrombus was completely resolved with oral dabigatran etexilate therapy.

摘要

1型强直性肌营养不良(DM1)是成人肌营养不良最常见的形式。它是一种常染色体显性遗传病,会累及多个系统。呼吸功能常受影响,呼吸衰竭是最常见的死亡原因。肺栓塞是DM1患者呼吸衰竭的罕见原因,因此这些患者的最佳抗凝策略仍不明确。我们描述了1例DM1患者发生肺栓塞的病例,该患者口服达比加群酯治疗后肺血栓完全溶解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f83a/6390112/7bedd62a3a69/am-2018-03-227-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f83a/6390112/57bcde695bc0/am-2018-03-227-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f83a/6390112/d3ab1455c429/am-2018-03-227-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f83a/6390112/7bedd62a3a69/am-2018-03-227-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f83a/6390112/57bcde695bc0/am-2018-03-227-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f83a/6390112/d3ab1455c429/am-2018-03-227-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f83a/6390112/7bedd62a3a69/am-2018-03-227-g003.jpg

相似文献

1
Myotonic dystrophy type 1 and pulmonary embolism: successful thrombus resolution with dabigatran etexilate therapy.1型强直性肌营养不良症与肺栓塞:达比加群酯治疗成功溶解血栓
Acta Myol. 2018 Sep 1;37(3):227-231. eCollection 2018 Sep.
2
Complete resolution of left atrial appendage thrombosis with oral dabigatran etexilate in a patient with Myotonic Dystrophy type 1 and atrial fibrillation.1型强直性肌营养不良合并心房颤动患者口服达比加群酯后左心耳血栓完全溶解
Acta Myol. 2017 Dec 1;36(4):218-222. eCollection 2017 Dec.
3
Recurrent pulmonary embolism during dabigatran treatment in a patient with immune thrombocytopenic purpura.
Thromb Res. 2016 Dec;148:23-24. doi: 10.1016/j.thromres.2016.10.012. Epub 2016 Oct 15.
4
Echocardiographic diagnosis, management and monitoring of pulmonary embolism with right heart thrombus in a patient with myotonic dystrophy: a case report.强直性肌营养不良患者合并右心血栓的肺栓塞的超声心动图诊断、管理及监测:一例报告
Cardiovasc Ultrasound. 2010 May 16;8:18. doi: 10.1186/1476-7120-8-18.
5
Is Dabigatran As Effective As Warfarin on Cardiac Thrombus in a Patient With Atrial Fibrillation? A Challenging Question.达比加群在房颤患者中预防心脏血栓形成的效果与华法林相当吗?一个具有挑战性的问题。
Am J Ther. 2016 May-Jun;23(3):e974-6. doi: 10.1097/MJT.0000000000000129.
6
Thrombolytic treatment of acute pulmonary embolism in myotonic dystrophy.
J Emerg Med. 2006 Feb;30(2):220-1. doi: 10.1016/j.jemermed.2005.12.012.
7
Dabigatran Etexilate: A Review in Nonvalvular Atrial Fibrillation.达比加群酯:非瓣膜性心房颤动的研究进展。
Drugs. 2017 Mar;77(3):331-344. doi: 10.1007/s40265-017-0699-z.
8
Pulmonary Embolism in a Collegiate Softball Athlete: A Case Report.一名大学垒球运动员的肺栓塞:病例报告
Curr Sports Med Rep. 2020 Feb;19(2):53-57. doi: 10.1249/JSR.0000000000000682.
9
RE-COVERY DVT/PE: Rationale and design of a prospective observational study of acute venous thromboembolism with a focus on dabigatran etexilate.RE-COVERY DVT/PE:一项关于急性静脉血栓栓塞症的前瞻性观察性研究的原理与设计,重点关注达比加群酯。
Thromb Haemost. 2017 Jan 26;117(2):415-421. doi: 10.1160/TH16-07-0566. Epub 2016 Nov 17.
10
The cost-utility of dabigatran etexilate compared with warfarin in treatment and extended anticoagulation of acute VTE in the UK.在英国,达比加群酯与华法林相比用于急性静脉血栓栓塞症治疗及延长抗凝治疗的成本效益分析
Thromb Haemost. 2015 Oct;114(4):778-92. doi: 10.1160/TH14-12-1027. Epub 2015 Aug 13.

引用本文的文献

1
Recurrent pulmonary embolism complicated with myotonic dystrophy type 1.复发性肺栓塞合并1型强直性肌营养不良
J Gen Fam Med. 2024 Jun 14;25(5):280-281. doi: 10.1002/jgf2.709. eCollection 2024 Sep.

本文引用的文献

1
Glomerular filtration rate: A prognostic marker in atrial fibrillation-A subanalysis of the AntiThrombotic Agents Atrial Fibrillation.肾小球滤过率:心房颤动的一个预后标志物——抗血栓药物治疗心房颤动的亚分析
Clin Cardiol. 2018 Dec;41(12):1570-1577. doi: 10.1002/clc.23065. Epub 2018 Dec 4.
2
Atrial Fibrillation and Malignancy: The Clinical Performance of Non-Vitamin K Oral Anticoagulants-A Systematic Review.心房颤动与恶性肿瘤:非维生素 K 口服抗凝剂的临床表现——系统评价。
Semin Thromb Hemost. 2019 Mar;45(2):205-214. doi: 10.1055/s-0038-1661386. Epub 2018 Aug 17.
3
Complete resolution of left atrial appendage thrombosis with oral dabigatran etexilate in a patient with Myotonic Dystrophy type 1 and atrial fibrillation.
1型强直性肌营养不良合并心房颤动患者口服达比加群酯后左心耳血栓完全溶解
Acta Myol. 2017 Dec 1;36(4):218-222. eCollection 2017 Dec.
4
Optimal left ventricular lead placement for cardiac resynchronization therapy in postmyocardial infarction patients.心肌梗死后患者心脏再同步治疗的最佳左心室电极放置位置。
Future Cardiol. 2018 May 1;14(3):215-224. doi: 10.2217/fca-2017-0046. Epub 2018 May 16.
5
Interatrial block to predict atrial fibrillation in myotonic dystrophy type 1.房间传导阻滞预测 1 型肌强直性营养不良的心房颤动。
Neuromuscul Disord. 2018 Apr;28(4):327-333. doi: 10.1016/j.nmd.2018.01.010. Epub 2018 Jan 31.
6
Effect of dual-chamber minimal ventricular pacing on paroxysmal atrial fibrillation incidence in myotonic dystrophy type 1 patients: A prospective, randomized, single-blind, crossover study.1 型肌强直性营养不良患者双腔最小心室起搏对阵发性心房颤动发生率的影响:一项前瞻性、随机、单盲、交叉研究。
Heart Rhythm. 2018 Jul;15(7):962-968. doi: 10.1016/j.hrthm.2018.03.008. Epub 2018 Mar 8.
7
Bachmann bundle pacing reduces atrial electromechanical delay in type 1 myotonic dystrophy patients.巴赫曼束起搏可减少1型强直性肌营养不良患者的心房电机械延迟。
J Interv Card Electrophysiol. 2018 Apr;51(3):229-236. doi: 10.1007/s10840-018-0331-5. Epub 2018 Feb 27.
8
Nonvitamin K Antagonist Oral Anticoagulants Use in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves/Prior Surgical Valve Repair: A Multicenter Clinical Practice Experience.非维生素 K 拮抗剂口服抗凝剂在心房颤动和生物瓣心脏瓣膜/既往手术瓣膜修复患者中的应用:一项多中心临床实践经验。
Semin Thromb Hemost. 2018 Jun;44(4):364-369. doi: 10.1055/s-0037-1615261. Epub 2018 Jan 5.
9
ACE inhibition to slow progression of myocardial fibrosis in muscular dystrophies.ACE 抑制作用可减缓肌营养不良症心肌纤维化的进展。
Trends Cardiovasc Med. 2018 Jul;28(5):330-337. doi: 10.1016/j.tcm.2017.12.006. Epub 2017 Dec 21.
10
Efficacy and safety of dabigatran in patients with atrial fibrillation scheduled for transoesophageal echocardiogram-guided direct electrical current cardioversion: a prospective propensity score-matched cohort study.达比加群酯在拟行经食管超声心动图引导直流电复律的心房颤动患者中的疗效和安全性:一项前瞻性倾向评分匹配队列研究。
J Thromb Thrombolysis. 2018 Feb;45(2):206-212. doi: 10.1007/s11239-017-1599-5.